Steven Caffé, M.D.
Senior Vice President, Regulatory Affairs
Dr. Caffé became our Senior Vice President for Regulatory Affairs in October 2014. Prior to joining Sucampo, he was Senior Vice President and Chief Development and Regulatory Officer at AMAG Pharmaceuticals Inc., a specialty pharmaceutical company, from June 2013 to October 2014.
From 2011 to 2013, Dr. Caffé served as Senior Vice President, Head of Global Regulatory Affairs and Patient Safety, at MedImmune LLC, the global biologics arm of AstraZeneca. Dr Caffé also served as Head of Global Regulatory Affairs, Pharmacovigilance and Asia Pacific Development, and co-chair of the Corporate Quality Council at Baxter International Inc. from 2006 to 2010.
From 2001 to 2005, Dr. Caffé was Vice President and Head of Global Regulatory Development at Aventis/Sanofi, and from 1992 to 2001, he held positions of increasing leadership at Merck & Co. in international and domestic Regulatory Affairs. Early in his career, Dr. Caffé served as a medical director for Parke-Davis France, before its acquisition by Pfizer.
Dr. Caffé began his career in medicine at the academic hospitals of Assistance Publique de Paris with a focus on emergency and intensive care.
Dr. Caffé earned a medical degree from the Faculté de Médecine Saint-Antoine, Université Pierre et Marie Curie (Paris 6) and completed his internship and residency at Internat des Hôpitaux.